Literature DB >> 12196032

Exercise recommendations in athletes with early osteoarthritis of the knee.

Vijay Vad1, Hoyman M Hong, Michael Zazzali, Nergis Agi, Dilshaad Basrai.   

Abstract

Osteoarthritis of the knee is a common condition that afflicts millions of individuals annually. The benefits of exercise are self evident as athletes and middle-aged individuals grow older, and the focus has centered on pain-free participation in their sports and activities. In the past, medical treatment has primarily relied on oral medications to manage symptoms, without the incorporation of therapeutic exercise. Consequently, as the osteoarthritis progresses, patients are offered surgical management and eventual joint replacement. A goal-oriented progressive rehabilitation programme that incorporates medical management in the initial stages would allow patients a greater ability to participate in sports, thereby obtaining the numerous benefits of exercise and perhaps delaying surgery. A progressive rehabilitation programme consists of five stages (I to V). Medical management is primarily reserved for stage I: protected mobilisation and pain control. It entails the use of pain medications, nonsteroidal anti-inflammatory drugs, with or without the use of chondroprotective agents such as glucosamine. Injection therapy is usually incorporated at this stage with intra-articular injections of corticosteroids or viscosupplementation, either of which may be combined with minimally invasive single-needle closed joint lavage procedure. Stages II and III introduce open kinetic-chain nonweightbearing exercises to the affected joint, with progression to closed kinetic-chain exercises. Stage IV focuses on return to sporting activities, with continued closed kinetic-chain exercises. There is also the incorporation of sport-specific exercises to improve neuromuscular coordination, timing and protect against future injury. Finally, stage V, or the maintenance phase, is primarily aimed at educating the patient on how to reduce the risk of re-injury and optimise their current exercise programme. Medical management of knee osteoarthritis within the framework of a progressive rehabilitation programme that includes active therapeutic exercise may delay the progression of this disease and allow patients years of greater pain-free activity and improved quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 12196032     DOI: 10.2165/00007256-200232110-00004

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  49 in total

1.  The effect of bracing on varus gonarthrosis.

Authors:  A Kirkley; S Webster-Bogaert; R Litchfield; A Amendola; S MacDonald; R McCalden; P Fowler
Journal:  J Bone Joint Surg Am       Date:  1999-04       Impact factor: 5.284

2.  Intra-articular hydrocortisone in arthritis and allied conditions; a summary of two years' clinical experience.

Authors:  J L HOLLANDER
Journal:  J Bone Joint Surg Am       Date:  1953-10       Impact factor: 5.284

3.  Mechanical disruption of human patellar cartilage by repetitive loading in vitro.

Authors:  N B Zimmerman; D G Smith; L A Pottenger; D R Cooperman
Journal:  Clin Orthop Relat Res       Date:  1988-04       Impact factor: 4.176

4.  Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study.

Authors:  M G Wilson; C J Michet; D M Ilstrup; L J Melton
Journal:  Mayo Clin Proc       Date:  1990-09       Impact factor: 7.616

Review 5.  Functional rehabilitation for the upper and lower extremity.

Authors:  S M Lephart; T J Henry
Journal:  Orthop Clin North Am       Date:  1995-07       Impact factor: 2.472

6.  Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.

Authors:  E W Ehrich; T J Schnitzer; H McIlwain; R Levy; F Wolfe; M Weisman; Q Zeng; B Morrison; J Bolognese; B Seidenberg; B J Gertz
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

7.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

8.  Risk factors for the incidence and progression of radiographic knee osteoarthritis.

Authors:  C Cooper; S Snow; T E McAlindon; S Kellingray; B Stuart; D Coggon; P A Dieppe
Journal:  Arthritis Rheum       Date:  2000-05

9.  Knee pain and disability in the community.

Authors:  T E McAlindon; C Cooper; J R Kirwan; P A Dieppe
Journal:  Br J Rheumatol       Date:  1992-03

10.  The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.

Authors:  M E Adams; M H Atkinson; A J Lussier; J I Schulz; K A Siminovitch; J P Wade; M Zummer
Journal:  Osteoarthritis Cartilage       Date:  1995-12       Impact factor: 6.576

View more
  8 in total

Review 1.  ISSN exercise & sports nutrition review update: research & recommendations.

Authors:  Chad M Kerksick; Colin D Wilborn; Michael D Roberts; Abbie Smith-Ryan; Susan M Kleiner; Ralf Jäger; Rick Collins; Mathew Cooke; Jaci N Davis; Elfego Galvan; Mike Greenwood; Lonnie M Lowery; Robert Wildman; Jose Antonio; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2018-08-01       Impact factor: 5.150

2.  Effectiveness of a long-term use of a minimalist footwear versus habitual shoe on pain, function and mechanical loads in knee osteoarthritis: a randomized controlled trial.

Authors:  Francis Trombini-Souza; Ricardo Fuller; Alessandra Matias; Mariane Yokota; Marco Butugan; Claudia Goldenstein-Schainberg; Isabel C N Sacco
Journal:  BMC Musculoskelet Disord       Date:  2012-07-12       Impact factor: 2.362

3.  Perioperative rehabilitation using a knee extension device and arthroscopic debridement in the treatment of arthrofibrosis.

Authors:  Angie Biggs-Kinzer; Brian Murphy; K Donald Shelbourne; Scott Urch
Journal:  Sports Health       Date:  2010-09       Impact factor: 3.843

4.  Effects of diet type and supplementation of glucosamine, chondroitin, and MSM on body composition, functional status, and markers of health in women with knee osteoarthritis initiating a resistance-based exercise and weight loss program.

Authors:  Teresa Magrans-Courtney; Colin Wilborn; Christopher Rasmussen; Maria Ferreira; Lori Greenwood; Bill Campbell; Chad M Kerksick; Erica Nassar; Rui Li; Mike Iosia; Matt Cooke; Kristin Dugan; Darryn Willoughby; LuAnn Soliah; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2011-06-20       Impact factor: 5.150

5.  Functional changes in muscle afferent neurones in an osteoarthritis model: implications for impaired proprioceptive performance.

Authors:  Qi Wu; James L Henry
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

6.  The effect of repetitive passive and active movements on proprioception ability in forearm supination.

Authors:  Ohsung Kwon; Seungwon Lee; Youngwoo Lee; Dongkwon Seo; Sangwoo Jung; Wonjae Chol
Journal:  J Phys Ther Sci       Date:  2013-06-29

7.  Vitamin C May Help to Reduce the Knee's Arthritic Symptoms. Outcomes Assessment of Nutriceutical Therapy.

Authors:  Umberto Ripani; Paloma Manzarbeitia-Arroba; Sandra Guijarro-Leo; Javier Urrutia-Graña; Alessandra De Masi-De Luca
Journal:  Med Arch       Date:  2019-06

8.  Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis.

Authors:  Kássya Mycaela Paulino Silva; Francisco Lucas de Sousa; Ana Carolina Barreto Alves; Pollyana Alves Rocha; Hildegard Naara Alves Furtado da Costa; Waldilene Rodrigues Ferreira; Taianara Sampaio Reis; Tharcia Kiara Beserra de Oliveira; Sandra Rejane Cabral Batista; Clovis José Cavalcanti Lapa Neto; Anne Gabrielle Oliveira; Ana Janaina Jeanine M de Lemos Jordão
Journal:  Heliyon       Date:  2021-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.